SCHEMBL588587

SCHEMBL588587

COC(C(F)(F)F)C(F)(F)F

nearest known ligand 0.35

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA9 Q16790 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methoxymethane SCHEMBL5135747 0.96 CA1 (0.33) CA1CA2CA9
SCHEMBL18652839 0.83 CA1 (0.31) CA1CA2CA9
SCHEMBL12219411 0.83 CA1 (0.31) CA1CA2CA9
SCHEMBL23251429 0.83 CA1 (0.31) CA1CA2CA9
SCHEMBL28938289 0.81
SCHEMBL31555958 0.81
SCHEMBL28938294 0.76
SCHEMBL8665222 0.76 CA1 (0.31) CA1CA2CA9
SCHEMBL28938274 0.74
SCHEMBL9559190 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1078 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120824418-B Polymer electrolyte and preparation method and application thereof Hunan Yihua New Energy Co.,Ltd. (CN) 2026-05-26 CN claimed
US-12640399-B2 Localized high salt concentration electrolyte WILDCAT DISCOVERY TECHNOLOGIES, INC. (US) 2026-05-26 US claimed
EP-4744105-A1 ALKALI-SULFUR SECONDARY BATTERY AND USE THEREOF Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2026-05-20 EP claimed
CN-121812753-B Wide-temperature-range high-voltage electrolyte and preparation method and application thereof 广东工业大学 2026-05-15 CN claimed
US-12603324-B2 Localized high salt concentration electrolyte WILDCAT DISCOVERY TECHNOLOGIES, INC. (US) 2026-04-14 US claimed
EP-4706123-A2 HALOGENATED ETHER-CONTAINING ELECTROLYTES Feon Energy, Inc. (US) 2026-03-11 EP claimed
US-12573655-B2 Lithium-sulfur secondary battery LG ENERGY SOLUTION, LTD. (KR) 2026-03-10 US claimed
US-20260051533-A1 ANODE SUPPORTED SOLID-STATE ELECTROLYTE SEPARATORS GM GLOBAL TECH OPERATIONS LLC (US) 2026-02-19 US claimed
US-20260031413-A1 ANODE-FREE LITHIUM BATTERY GM Global Technology Operations LLC (US) 2026-01-29 US claimed
US-20260011788-A1 LOCALIZED HIGH SALT CONCENTRATION ELECTROLYTE Wildcat discovery technologies inc (US) 2026-01-08 US claimed
CN-1431987-A Synthetic method for fluoromethylation of halogenated alcohols ABBOTT LAB (US) 2003-07-23 CN claimed
EP-1303258-A1 NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE AstraZeneca AB (SE) 2003-04-23 EP claimed
EP-1268381-A1 PRODUCTION OF FLUORMETHYL 2,2,2-TRIFLUORO-1-(TRIFLUOROMETHYL)ETHYL ETHER Halocarbon Products Corporation (US) 2003-01-02 EP claimed
WO-2002098831-A2 PROCESS FOR REMOVAL OF DIMETHYL ETHER IN THE SYNTHESIS OF SEVOFLURANE BAXTER INTERNATIONAL INC. (US) 2002-12-12 WO claimed
US-6448451-B1 EVAPORATING BY PASSING A GAS STREAM THROUGH THE COMPOSITION; PURIFYING METHYL 2,2,2-TRIFLUORO-1-(TRIFLUOROMETHYL)ETHYL ETHER INTERMEDIATE BAXTER INTERNATIONAL, INC. 2002-09-10 US claimed
WO-2002003958-A1 NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE ASTRAZENECA AB (SE) 2002-01-17 WO claimed
WO-2001068577-A1 PRODUCTION OF FLUORMETHYL 2,2,2-TRIFLUORO-1-(TRIFLUOROMETHYL)ETHYL ETHER HALOCARBON PRODUCTS CORPORATION (US) 2001-09-20 WO claimed
EP-0830436-A1 REFRIGERANTS BASED ON HYDROFLUOROETHER OF FLUOROETHER E.I. DU PONT DE NEMOURS & CO. (INC.) (US) 1998-03-25 EP claimed
WO-1997039081-A1 1,1,2,2,3,3,4,4-OCTAFLUOROBUTANE COMPOSITIONS E.I. DU PONT DE NEMOURS AND COMPANY (US) 1997-10-23 WO claimed
WO-1996040834-A1 REFRIGERANTS BASED ON HYDROFLUOROETHER OF FLUOROETHER E.I. DU PONT DE NEMOURS AND COMPANY (US) 1996-12-19 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260011788-A1 LOCALIZED HIGH SALT CONCENTRATION ELECTROLYTE SLC8A1, NCS1, CACNA1S CA1 34/4885CA2 150/4885CA9 986/4885
US-20260031413-A1 ANODE-FREE LITHIUM BATTERY LSM8, NES, CACNA1S CA1 167/4885CA2 1134/4885CA9 2196/4885
US-12603324-B2 Localized high salt concentration electrolyte MAPT, SLC8A1, SLC6A6 CA1 135/4885CA2 172/4885CA9 1275/4885
US-12573655-B2 Lithium-sulfur secondary battery HCN2, HCN4, CACNA1F CA1 88/4885CA2 143/4885CA9 900/4885
US-12640399-B2 Localized high salt concentration electrolyte SLC8A1, SLC6A6, SLC20A1 CA1 242/4885CA2 273/4885CA9 1668/4885
US-20260051533-A1 ANODE SUPPORTED SOLID-STATE ELECTROLYTE SEPARATORS XPO4, XPA, CACNA2D4 CA1 35/4885CA2 36/4885CA9 285/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.